Silver Sulfadiazine
Silver Sulfadiazine is a pharmaceutical drug with 6 clinical trials. Historical success rate of 50.0%.
Success Metrics
Based on 2 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
0
Mid Stage
3
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
40.0%
2 of 5 finished
60.0%
3 ended early
0
trials recruiting
6
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Silver Sulfadiazine With Hyaluronic Acid Versus Silver Sulfadiazine Alone in Partial-Thickness Burns
Effectiveness of KeraStat Gel for Improved Cosmesis of Partial Thickness Burns
StrataXRT for the Prevention and Treatment of Radiation Dermatitis in Breast Cancer or Head and Neck Cancer Patients
Superficial Partial-Thickness Burn Study
Comparative Analysis of Cost-effectiveness of Silver Dressing in Burns
Clinical Trials (6)
Silver Sulfadiazine With Hyaluronic Acid Versus Silver Sulfadiazine Alone in Partial-Thickness Burns
Effectiveness of KeraStat Gel for Improved Cosmesis of Partial Thickness Burns
StrataXRT for the Prevention and Treatment of Radiation Dermatitis in Breast Cancer or Head and Neck Cancer Patients
Superficial Partial-Thickness Burn Study
Comparative Analysis of Cost-effectiveness of Silver Dressing in Burns
Comparison of a Water-soluble Topical Antimicrobial to Silver Sulfadiazine in Partial Thickness Burns
All 6 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 6